Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 44

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 44
---
 agreements
also set forth certain procedures that will apply in the event of a claim for indemnification or advancement of expenses, including,
among others, provisions about submitting a written request to us that includes such documentation and information as is reasonably available
to the director or executive officer and is reasonably necessary to determine entitlement to indemnification and provisions.

<div align='center'>II-2</div>

Item 16. Exhibits.

EXHIBIT INDEX

| Exhibit 
 Number  
 3.1     
 3.2     |     | Description                                                                                                                                                                                                                                                     
 Fourth Amended and Restated Certificate of Incorporation of the Company, as amended [Restated for SEC filing purposes only] (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2025).       
 Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.4 to the Company’s Registration Statement on Form S-1, filed with the SEC on December 6, 2016).                                                                              |
|:--------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.1     |     | Form of Common Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 15, 2025).                                                                                                          |
| 4.2     |     | Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed with the SEC on October 15, 2025).                                                                                                      |
| 4.3     |     | Form of Arca Warrant (incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K, filed with the SEC on October 15, 2025).                                                                                                            |
| 4.4     |     | Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K, filed with the SEC on October 15, 2025).                                                                                                 |
| 5.1*    |     | Opinion of K&L Gates LLP.                                                                                                                                                                                                                                       |
| 10.1    |     | Securities Purchase Agreement, dated as of October 10, 2025, between ENDRA Life Sciences Inc,